Verition Fund Management LLC Cytokinetics Inc Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 20,282 shares of CYTK stock, worth $875,979. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,282
Previous 45,000
54.93%
Holding current value
$875,979
Previous $2.38 Million
59.85%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
114MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$634 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$515 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$464 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$266 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$123 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.07B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...